myelogenous

1 The first is the blood cell-forming organ. This is the site where myelogenous leukemia begins.

它首先是血细胞形成器官，髓细胞白血病即从此发源。

2 At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here.

在高倍镜下，见到的是急性髓母细胞白血病骨髓。

3 In an embodiment of the fourth aspect, the malignancy is relapsed acute myelogenous leukemia.

在第四方面的实施方案中，所述恶性肿瘤是肉瘤。

4 At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here.

在高倍镜下, 见到的是急性髓母细胞白血病骨髓.

5 Objective To investigate the changes of serum VEGF and SE-CAD levels in patients with acute myelogenous leukemia after treatment.

目的探讨了急性髓系白血病患者治疗前后血清vegf和SE - CAD水平的变化。

6 Finally, phagocyte precursors may undergo malignant transformation, which results in acute or chronic myelogenous leukemia.

到最后，吞噬细胞前体可能发生恶变，导致急性或慢性骨髓性白血病。

7 Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).

目的：探讨慢性粒细胞白血病（CML）患者BCR/ABL融合基因表达与中医辨证分型的关系。

8 In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.

在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。

9 The drug blocks a mutant protein that causes chronic myelogenous leukemia (CML), becoming the first chemotherapy to specifically target cancer cells.

该药可以阻断引起慢性髓细胞性白血病（CML）的突变蛋白，成为第一个特异靶向癌细胞的化学药。

10 Compared with acute myelogenous leukemia, patients with acute lymphoblastic leukemia had more poor cellular immune function.

与急性髓细胞性白血病相比，急性淋巴细胞性白血病细胞免疫功能更为低下。

11 Conclusion The combination regimen of HHT and Ara cis effective and economical in patient with late chronic-phase chronic myelogenous leukemia(CML).

结论高三尖杉酯碱联合低剂量阿糖胞苷治疗慢粒白血病急变简便，经济，有效。

12 To summarize and analyze curative effect on 52 cases of Chronic Myelogenous Leukemia (CML) by clearing away liver fire and dispersing blood stasis.

总结分析以清肝化瘀法为主治疗慢性粒细胞白血病5 2例的远期疗效。

13 In an embodiment of the first aspect, the acute myelogenous leukemia is relapsed acute myelogenous leukemia.

在第一方面的实施方案中，所述急性髓性白血病是复发性急性髓性白血病。

14 Tests of 187 other patients with acute myelogenous leukemia found that none had the eight new mutations found in the first patient.

其他187例急性髓细胞性白血病患者的实验中，均没有发现第一例病人中发现的8个新的基因突变。

15 Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.

急性骨髓性白血病(aml)是指血液中和骨髓中的细胞发生了癌变——骨髓是指骨内作为造血场所的海绵组织。

16 Objective The purpose of this study is to find the relationship and significance between the expression of JWA gene and chronic myelogenous leukemia (CML).

目的探讨JWA基因表达与慢性粒细胞性白血病（CML）的相关意义。

17 BCRABL; tyrosine kinases; inhibitors; chronic myelogenous leukemia; review.

bcrabl；酪氨酸激酶；抑制剂；慢性粒细胞白血病；综述。

18 Objective to carry out health education of patients with chronic myelogenous leukemia to improve patients self - conservancy and life quality.

目的对慢性粒细胞白血病患者进行健康教育，提高患者的自我保健能力和生活质量。

19 Craig Thompson, the president and CEO of Memorial Sloan-Kettering Cancer Center, recently launched Agios Pharmaceuticals, which is testing drugs against a mutant enzyme that drives metabolism in acute myelogenous leukemia.

20 Chronic myelogenous leukemia ( CML ) is a clonal myeloproliferative disease of transformed hematopoietic progenitor cells.

慢性粒细胞白血病 ( chronicmyelogcnousleukemia, CML ) 是一种以髓系细胞受累为主的多能造血干细胞的克隆性疾病.

1 骨髓

medullary marrow medulla pith

2 骨髓的

medullary